Avanos Medical (AVNS) Free Cash Flow (2013 - 2026)

Avanos Medical has reported Free Cash Flow for 14 years, with the latest figure at -$16.6 million in Q1 2026.

• Quarterly Free Cash Flow fell 187.37% year-over-year to -$16.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.5 million (down 70.29% YoY) and the FY2025 annual result came in at $73.1 million, down 23.13% from the prior year.
• Free Cash Flow eased to -$16.6 million in Q1 2026 per AVNS's latest filing, from $51.3 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $65.3 million in Q4 2024 and troughed at -$16.6 million in Q1 2026.
• A 5-year average of $14.9 million and a median of $19.0 million in 2025 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow slumped 237.5% in 2023, then soared 860.29% in 2024.
• Over 5 years, Free Cash Flow stood at $44.2 million in 2022, then slumped by 84.62% to $6.8 million in 2023, then jumped by 860.29% to $65.3 million in 2024, then retreated by 21.44% to $51.3 million in 2025, then sank by 132.36% to -$16.6 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$16.6 million, $51.3 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.